Article

A sustainable specialty pharmacy starts with the care model

  • Ryan Telford, PharmD

Growth in prescriptions can mask gaps in how patients get on therapy and how the program is supported. Following his Advisory Board webinar conversation with Ken Komorny, Chief Pharmacy Officer at Moffitt Cancer Center, Ryan Telford outlines the questions health system leaders should ask to build a specialty pharmacy program that keeps caring for patients if the assumptions behind its growth change.

More prescriptions. More growth. A stronger specialty pharmacy program. It is easy to assume those things move together, but they don’t always. A pharmacy can increase volume and still have patients caught between segmented teams, access work that is harder than it needs to be, and economics that depend too heavily on one source of support. The question I want leaders to ask is straightforward: Are we building a program that can keep caring for patients if the assumptions behind that growth change?

I explored that question with Ken Komorny, Chief Pharmacy Officer at Moffitt Cancer Center, in Advisory Board’s webinar on financial sustainability in specialty pharmacy. As a non-340B-eligible health system, Moffitt brings a unique perspective to a challenge every system faces: connecting clinical care, the work of getting patients on therapy, and the economics that sustain the pharmacy program. Here, I want to build on that conversation by focusing on the questions leaders should ask themselves as they design a sustainable specialty pharmacy program within their health system.

Build a shared enterprise strategy for
specialty care

For a patient whose provider prescribes a specialty therapy, getting started often involves much more than a trip to the corner pharmacy. The prescription must reach the right team to determine coverage, complete prior authorization, identify any need for financial assistance, and coordinate where it can be filled. Along the way, patients need navigation and education to understand the next steps and get the most out of treatment, while the pharmacist stays connected to the provider as therapy changes. Making that journey work requires coordination across the health system.

Ken’s description of pharmacists working directly with providers and supporting patients throughout treatment offers a starting point for thinking about that coordination. Pharmacy is central to this effort, working with providers, clinical and administrative staff, patient access, ambulatory operations, finance, revenue cycle, social services, and others to keep care connected. When those teams develop workflows in isolation, patients are left navigating the gaps between them. A shared enterprise strategy brings their work together around a common plan for delivering specialty care.

Pharmacy leadership plays a critical role in shaping that strategy from the outset. Their perspective helps the broader team connect care-delivery decisions with the practical work of getting medications to patients and supporting them throughout treatment. But for specialty pharmacy to reach its full potential, it has to be a connected enterprise strategy. 

Evaluate investment and savings through their impact on care

The coordination patients need also takes people and resources. Prior authorization, financial assistance, and patient navigation help patients secure coverage, afford therapy, and understand what to do next. As leaders evaluate the cost of that support, they need to consider what that support enables downstream in the patient journey.

These early interactions are the opportunity to remove barriers, explain the next steps, and keep care connected. Through that work, teams can identify prescriptions the health system could serve internally further maintaining care continuity and keeping dollars close to care. Thoughtful access support can therefore help patients move forward with therapy while strengthening the program.

That connection between resources and patient impact belongs at the center of the financial discussion. Leaders should consider where they need to invest to deliver specialty pharmacy care, as well as where duplicated or disconnected work consumes resources or creates gaps in care. Together, those questions help leaders weigh potential savings against their effect on care and the program’s ability to deliver it.

Make the value of integrated pharmacy visible

Keeping specialty prescriptions inside the system keeps health care dollars close to care and creates an opportunity to track the broader impact on patients and the organization. Ken described pharmacists working directly with providers, educating patients, following therapy changes, and recognizing when a medication has been stopped so an unnecessary refill does not go out. Those interactions add connectivity and visibility to the specialty care journey that allow additional value to be measured.

If the only number we bring to leadership is prescriptions dispensed or revenue, much of that work stays invisible. Show what the model is doing for patients.  Quantify how those elevated patient outcomes impact the organization’s quality and operational benchmarks.  Connect this to the resources required to do it.

Here is what I would want to know as a leader:

  • How quickly are patients able to begin therapy and where do delays occur?
  • Which financial and access barriers are being resolved and which remain?
  • How are pharmacists staying connected to therapy changes and ongoing patient needs?
  • What evidence demonstrates clinical benefit, avoided unnecessary utilization, or lower total cost?
  • Can we connect those results to the resources required to deliver them?

That insight gives organizations real data to bring to payers, manufacturers, and other stakeholders which can have meaningful impact on financial sustainability. Outcomes do not automatically open a network or change reimbursement; but they put health systems and integrated providers in the best position to take full advantage of value-based constructs where they exist. 

What happens if your biggest source of support changes?

Moffitt’s experience as a non-340B-eligible health system brings the question of financial dependence into focus. A program can look strong today and still depend heavily on one financial assumption. For participating systems, 340B savings can be critical to support the patient care they deliver. That matters. Knowing what those savings support, however, is different from knowing what the program could sustain if they changed. Leaders need to understand both.

I would rather have that discussion while there is still room to make decisions. Bring pharmacy and finance together. Put the assumptions on the table. Then work through what a change would actually mean:

  • Which assumptions does the program depend on most heavily?
  • If that assumption changes, which patient services and operating capabilities are exposed?
  • Where are disconnected processes or capability gaps making the program more expensive to run?
  • What would it realistically take in expertise, resources, and time to close those gaps?

Understanding what sustainability is leaned against gives leaders time to build resilience in key service lines like specialty pharmacy. If a change would put those services at risk, identify the gap now and assess the options for closing it. That work takes expertise, resources, and time. Planning ahead gives you room to make those decisions before you need to act.

Own the program. Be deliberate about what you build.

Owning your specialty pharmacy strategy means knowing what the program needs to do and staying accountable for its direction. Keeping pharmacists connected to patients and providers is central to that model. Decide which analytical tools, access workflows, and specialized support functions to develop internally based on what the program needs and clearly define where outside expertise could help.

Our Accelerate Pharmacy Solutions team starts with simply evaluating what the health system does well and where it may need support. That might mean defining a performance roadmap, evaluating market opportunities, designing patient access and affordability capabilities or building a full enterprise plan. We focus on closing specific gaps and driving speed to value in ways that fits the organization’s strategy and how its teams deliver care.

If your health system is evaluating a partner, make the conversation practical. What will this relationship help us do that we cannot do well today? How does it fit the way our teams deliver care? What will we still own? How will we know it is working? Will this relationship make us more sustainable or more dependent in the long run? Evaluate the services offered against those questions to understand how well the relationship fits your operating model.

Here is where I would start

You do not need to solve every part of this in one strategy session. Volume is a useful indicator of growth. Assess it alongside how teams work together, which capabilities need investment, and how the care model would hold up if the economics changed. Use that broader view of sustainability to challenge the assumptions behind your growth target.

Bring these three questions to your next leadership discussion:

  1. Are we building an enterprise strategy, or asking pharmacy to solve an enterprise problem alone?
  2. What happens to our care model if the financial support we rely on most changes?
  3. Which capability gaps matter most, and what would it realistically take to close them?

Use the answers to decide what comes next. Start with the care that your patients need and be specific about what it takes to deliver it, then build the capabilities and economics to keep doing it.

Watch the webinar recording

Watch my conversation with Ken Komorny in Advisory Board’s Building financial sustainability in specialty pharmacy webinar for a closer look at the decisions behind a more resilient, integrated program. The current environment is dynamic and challenging but organizations like Moffitt prove you can deliver high-quality care with excellence with the right plan.

Understand where your specialty pharmacy opportunity begins

If your organization needs a clearer view of the opportunity before deciding what to build next, start by sizing it. An initial assessment helps determine whether the potential warrants a more detailed implementation discussion.

Accelerate Pharmacy Solutions’ complimentary Specialty Pharmacy Opportunity Assessment provides an initial view of potential specialty pharmacy opportunity and a starting point for discussing next steps.

Use that starting point to focus the leadership conversation: Is there a meaningful opportunity, what would pursuing it require, and how does it fit the care model your organization wants to deliver?

Ressources connexes

Rapport

Perspectives pour les pharmacies : Édition d’automne 2026

Article

Why referral management is critical to infusion service line success

Article

Des données aux résultats : Une approche de 90 jours pour améliorer le rendement des pharmacies spécialisées du système de santé